{
    "id": 103,
    "premise": "none",
    "hypothesis": "an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients",
    "label": "entailment",
    "explanation": "an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients",
        "refined explanation": "An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients and may overcome treatment resistance.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.\nTargeting the HER2 kinase domain with an irreversible inhibitor is expected to overcome treatment resistance.\nThe HER V777L mutation is associated with the HER2 kinase domain, and targeting this mutation can help overcome treatment resistance.",
        "refined iteration": 2,
        "history explanation": [
            "0 iteration: an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
            "1 iteration: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients and may overcome treatment resistance.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.",
            "2 iteration: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients and may overcome treatment resistance.\nTargeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance.\nTargeting the HER2 kinase domain with an irreversible inhibitor is expected to overcome treatment resistance.\nThe HER V777L mutation is associated with the HER2 kinase domain, and targeting this mutation can help overcome treatment resistance."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides that an irreversible inhibitor targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients. *)\\n(* This aligns with the logical relation Implies(A, B). *)\\n(* We can infer that there exists an event e2 where the inhibitor is effective for breast cancer patients. *)\\nthen have \"\u2203e2. Effective e2 \u2227 Agent e2 x \u2227 BreastCancerPatients z\" sledgehammer', 'solving time': 104.40579867362976, 'proof tactics': [], 'code': 'theory clinical_103_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitor :: \"entity \u21d2 bool\"\\n  TargetedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  HER2KinaseDomain :: \"entity \u21d2 bool\"\\n  Expected :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  EffectiveDrug :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  BreastCancerPatients :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n  HERV777LMutation :: \"entity \u21d2 bool\"\\n  TyrosineKinase :: \"entity \u21d2 bool\"\\n  With :: \"event \u21d2 entity \u21d2 bool\"\\n  Overcome :: \"event \u21d2 bool\"\\n  TreatmentResistance :: \"entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: an irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 Expected e \u2227 Agent e x \u2227 EffectiveDrug e \u2227 For e z \u2227 BreastCancerPatients z\"\\n\\n(* Explanation 2: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Targeting e \u2227 HERV777LMutation x \u2227 Inhibitor y \u2227 TyrosineKinase y \u2227 With e y \u2227 Overcome e \u2227 Agent e x \u2227 TreatmentResistance z \u2227 Patient e z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\"\\n  (* Hypothesis: an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients *)\\n  shows \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 BreastCancerPatients z\"\\nproof -\\n  (* From the premise, we have known information about the inhibitor, its targeting, and the conditions of treatment resistance and breast cancer patients. *)\\n  from asm have \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\" <ATP>\\n  \\n  (* Explanation 1 provides that an irreversible inhibitor targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients. *)\\n  (* This aligns with the logical relation Implies(A, B). *)\\n  (* We can infer that there exists an event e2 where the inhibitor is effective for breast cancer patients. *)\\n  then have \"\u2203e2. Effective e2 \u2227 Agent e2 x \u2227 BreastCancerPatients z\" <ATP>\\n  \\n  (* Explanation 2 provides that targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\n  (* This aligns with the logical relation Implies(C, D). *)\\n  (* We can infer that there exists an event e1 where the inhibitor overcomes treatment resistance. *)\\n  then have \"\u2203e1. Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z\" <ATP>\\n  \\n  (* Combining these inferences, we can conclude the hypothesis. *)\\n  then show \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 BreastCancerPatients z\" <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: an irreversible inhibitor is targeted to the HER2 kinase domain (from Explanatory Sentence 1)\\nB: it is expected to be an effective drug for breast cancer patients (from Explanatory Sentence 1)\\nC: targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor (from Explanatory Sentence 2)\\nD: it may overcome treatment resistance (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, it is expected to be an effective drug for breast cancer patients)\\n--------\\nImplies(C, D)\\nImplies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, it may overcome treatment resistance)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(A, And(B, C)), which implies that an irreversible inhibitor targeted to the HER2 kinase domain is both effective for breast cancer patients and can overcome treatment resistance. *)\\n(* A is from explanatory sentence 1, B and C are from explanatory sentence 1. *)\\n(* We already have Inhibitor x, TargetedTo x y, and HER2KinaseDomain y, so we can infer both Effective and Overcome. *)\\nthen have \"Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 In e2 z\" sledgehammer', 'solving time': 103.44240999221802, 'proof tactics': [], 'code': 'theory clinical_103_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitor :: \"entity \u21d2 bool\"\\n  TargetedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  HER2KinaseDomain :: \"entity \u21d2 bool\"\\n  Drug :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  BreastCancerPatients :: \"entity \u21d2 bool\"\\n  TreatmentResistance :: \"entity \u21d2 bool\"\\n  Overcome :: \"event \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  HERV777L :: \"entity \u21d2 bool\"\\n  TyrosineKinase :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients and may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 Drug z \u2227 Effective e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 BreastCancerPatients z \u2227 TreatmentResistance z \u2227 Overcome e2 \u2227 Agent e2 x \u2227 Patient e2 z\"\\n\\n(* Explanation 2: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Mutation x \u2227 HERV777L x \u2227 Inhibitor y \u2227 TyrosineKinase y \u2227 Targeting e \u2227 Agent e y \u2227 Patient e x \u2227 TreatmentResistance z \u2227 Overcome e \u2227 Agent e y \u2227 Patient e z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\"\\n  (* Hypothesis: an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients *)\\n  shows \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 In e2 z \u2227 BreastCancerPatients z\"\\nproof -\\n  (* From the premise, we have known information about the inhibitor, targeting, HER2 kinase domain, treatment resistance, and breast cancer patients. *)\\n  from asm have \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\" <ATP>\\n  (* There is a logical relation Implies(A, And(B, C)), which implies that an irreversible inhibitor targeted to the HER2 kinase domain is both effective for breast cancer patients and can overcome treatment resistance. *)\\n  (* A is from explanatory sentence 1, B and C are from explanatory sentence 1. *)\\n  (* We already have Inhibitor x, TargetedTo x y, and HER2KinaseDomain y, so we can infer both Effective and Overcome. *)\\n  then have \"Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 In e2 z\" <ATP>\\n  (* Combine the inferred information with the known information to satisfy the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: an irreversible inhibitor is targeted to the HER2 kinase domain (from Explanatory Sentence 1)\\nB: be an effective drug for breast cancer patients (from Explanatory Sentence 1)\\nC: overcome treatment resistance (from Explanatory Sentence 1 and 2)\\nD: targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, B & C)\\n--------\\nImplies(D, C)\\nImplies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, overcome treatment resistance)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, overcome treatment resistance)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(be an effective drug for breast cancer patients), Not(an irreversible inhibitor is targeted to the HER2 kinase domain))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(overcome treatment resistance), Not(an irreversible inhibitor is targeted to the HER2 kinase domain))\\n--------\\nImplies(A, B)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, be an effective drug for breast cancer patients)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 31.248550176620483, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'cvc4: Try this: using explanation_1 by blast (9 ms)', 'cvc4 found a proof...', 'zipperposition: Found duplicate proof', 'cvc4 found a proof...', 'verit found a proof...', 'cvc4: Found duplicate proof', 'cvc4: Found duplicate proof', 'vampire found a proof...', 'verit: Found duplicate proof', 'zipperposition found a proof...', 'zipperposition: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition found a proof...', 'zipperposition: Found duplicate proof', 'e found a proof...', 'e: Found duplicate proof', 'Done'], 'code': 'theory clinical_103_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitor :: \"entity \u21d2 bool\"\\n  TargetedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  HER2KinaseDomain :: \"entity \u21d2 bool\"\\n  Drug :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  BreastCancerPatients :: \"entity \u21d2 bool\"\\n  TreatmentResistance :: \"entity \u21d2 bool\"\\n  Overcome :: \"event \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  HER_V777L :: \"entity \u21d2 bool\"\\n  TyrosineKinase :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n  Associated :: \"event \u21d2 bool\"\\n  Help :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: An irreversible inhibitor that is targeted to the HER2 kinase domain is expected to be an effective drug for breast cancer patients and may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 Drug z \u2227 Effective e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 BreastCancerPatients z \u2227 TreatmentResistance z \u2227 Overcome e2 \u2227 Agent e2 x \u2227 Patient e2 z\"\\n\\n(* Explanation 2: Targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor may overcome treatment resistance. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Mutation x \u2227 HER_V777L x \u2227 Inhibitor y \u2227 TyrosineKinase y \u2227 Targeting e \u2227 Agent e y \u2227 Patient e x \u2227 TreatmentResistance z \u2227 Overcome e \u2227 Agent e y \u2227 Patient e z\"\\n\\n(* Explanation 3: Targeting the HER2 kinase domain with an irreversible inhibitor is expected to overcome treatment resistance. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e. HER2KinaseDomain x \u2227 Inhibitor y \u2227 Targeting e \u2227 Agent e y \u2227 Patient e x \u2227 TreatmentResistance z \u2227 Overcome e \u2227 Agent e y \u2227 Patient e z\"\\n\\n(* Explanation 4: The HER V777L mutation is associated with the HER2 kinase domain, and targeting this mutation can help overcome treatment resistance. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z e1 e2. Mutation x \u2227 HER_V777L x \u2227 HER2KinaseDomain y \u2227 Associated e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Targeting e2 \u2227 Agent e2 x \u2227 Help e2 \u2227 Overcome e2 \u2227 TreatmentResistance z \u2227 Patient e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\"\\n  (* Hypothesis: an irreversible inhibitor that is targeted to the HER2 kinase domain may overcome treatment resistance and be effective in breast cancer patients *)\\n  shows \"\u2203x y z e1 e2. Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 Overcome e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Effective e2 \u2227 Agent e2 x \u2227 BreastCancerPatients z\"\\nproof -\\n  (* From the premise, we have known information about the inhibitor, targeting, HER2 kinase domain, treatment resistance, and breast cancer patients. *)\\n  from asm have \"Inhibitor x \u2227 TargetedTo x y \u2227 HER2KinaseDomain y \u2227 TreatmentResistance z \u2227 BreastCancerPatients z\" <ATP>\\n  (* There is a logical relation Implies(A, And(B, C)), which implies that an irreversible inhibitor targeted to the HER2 kinase domain leads to being an effective drug for breast cancer patients and overcoming treatment resistance. *)\\n  (* A is from explanatory sentence 1, B and C are from explanatory sentence 1. *)\\n  (* We already have Inhibitor x, TargetedTo x y, and HER2KinaseDomain y, so we can infer Effective e2 and Overcome e1. *)\\n  then have \"Overcome e1 \u2227 Effective e2 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Agent e2 x \u2227 BreastCancerPatients z\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: an irreversible inhibitor is targeted to the HER2 kinase domain (from Explanatory Sentence 1)\\nB: be an effective drug for breast cancer patients (from Explanatory Sentence 1)\\nC: overcome treatment resistance (from Explanatory Sentence 1, 2, 3, and 4)\\nD: targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor (from Explanatory Sentence 2)\\nE: targeting the HER2 kinase domain with an irreversible inhibitor (from Explanatory Sentence 3)\\nF: the HER V777L mutation is associated with the HER2 kinase domain (from Explanatory Sentence 4)\\nG: targeting the HER V777L mutation (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, B & C)\\n--------\\nImplies(D, C)\\nImplies(targeting the HER V777L mutation with an irreversible tyrosine kinase inhibitor, overcome treatment resistance)\\n--------\\nImplies(E, C)\\nImplies(targeting the HER2 kinase domain with an irreversible inhibitor, overcome treatment resistance)\\n--------\\nImplies(F, G)\\nImplies(the HER V777L mutation is associated with the HER2 kinase domain, targeting the HER V777L mutation)\\n--------\\nImplies(G, C)\\nImplies(targeting the HER V777L mutation, overcome treatment resistance)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, overcome treatment resistance)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(be an effective drug for breast cancer patients), Not(an irreversible inhibitor is targeted to the HER2 kinase domain))\\n--------\\nImplies(Not(C), Not(F))\\nImplies(Not(overcome treatment resistance), Not(the HER V777L mutation is associated with the HER2 kinase domain))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(overcome treatment resistance), Not(an irreversible inhibitor is targeted to the HER2 kinase domain))\\n--------\\nImplies(A, B)\\nImplies(an irreversible inhibitor is targeted to the HER2 kinase domain, be an effective drug for breast cancer patients)\\n--------\\nImplies(F, C)\\nImplies(the HER V777L mutation is associated with the HER2 kinase domain, overcome treatment resistance)\\n--------\\n'}"
        ]
    }
}